Article Versions Notes

Antypenko L, Meyer F, Sadyk Z, Shabelnyk K, Kovalenko S, Steffens KG, Garbe L-A. Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: In Vitro Growth Inhibition and In Silico Molecular Docking Analysis to Fungal Chitin Deacetylase. Journal of Fungi. 2023; 9(1):79. https://doi.org/10.3390/jof9010079

Antypenko, Lyudmyla, Fatuma Meyer, Zhanar Sadyk, Konstyantyn Shabelnyk, Sergiy Kovalenko, Karl Gustav Steffens, and Leif-Alexander Garbe. 2023. "Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: In Vitro Growth Inhibition and In Silico Molecular Docking Analysis to Fungal Chitin Deacetylase" Journal of Fungi 9, no. 1: 79. https://doi.org/10.3390/jof9010079

Antypenko, L., Meyer, F., Sadyk, Z., Shabelnyk, K., Kovalenko, S., Steffens, K. G., & Garbe, L.-A. (2023). Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1H-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: In Vitro Growth Inhibition and In Silico Molecular Docking Analysis to Fungal Chitin Deacetylase. Journal of Fungi, 9(1), 79. https://doi.org/10.3390/jof9010079